Delivered virtually Monday 4th October 2021
In our first Investor Q&A article, Roel Bulthuis, Managing Partner of INKEF Capital shares his thoughts on the investment landscape in Europe.
One Nucleus’ BioWednesday Webinar discussed what R&D is underway to treat the effects of concussions, how new technologies are enabling better diagnoses…
New funding is available for the UK’s most promising life sciences companies, with the potential to crowd in further funding from other investors…
Optimum is pleased to announce the appointment of Stella Lempidaki. With a … Continue reading “Optimum Strategic Communications Expands Team to support ongoing growth”
Mike Ward, Global Head of Thought Leadership at Decision Resources Group, part … Continue reading “If I Knew Then, What I Know Now”
In April 2020 Kate Bingham was invited by Sir Patrick Vallance, the … Continue reading “Dame Kate Bingham’s Keynote from the 17th Anglonordic life science conference”
Optimum is proud to partner with The LSX Nordic Congress, one of the leading strategy, investment and partnering conference for the Nordic life science and healthcare industry. Register now…
Optimum supports One Nucleus’ flagship conference, ON Helix, which brings the network … Continue reading “ON Helix Digital Conference 2021”
Amber Tong, Senior Editor at Endpoints, chaired a fantastic panel of Europe’s … Continue reading “Takeaways from EU VCs Panel Discussion at Anglonordic Life Science Conference”
Top takeaways from the BSCC – Panel | Investment in Healthcare – where the professionals are investing.
Congratulations to all those listed in InVivo’s list of 30 Rising Leaders … Continue reading “InVivo’s 30 Rising Leaders 2021”
Optimum are proud sponsors of the European Mediscience Awards. Optimum is again … Continue reading “European Mediscience Awards 2021 Short list announced”
Save The Date: 5th – 6th July 2021 speakers from eTheRNA, Lilly, Versameb & Thermo Fisher Scientific will contribute to a panel discussion on ‘mRNA Beyond Vaccine’
To celebrate, we asked the brilliant women in our sector their one main positive to come from the pandemic.
Paul Major, fund manager, BB Healthcare Trust shares his thoughts on the … Continue reading “Vaccines’ Progress: Paul Major Interview”
Optimum supports Anglonordic, the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other.
European innovators helped pave the way for the world’s first COVID-19 vaccines. What’s coming next from Europe’s academic and biotech leaders?
To be credible and investible, ESG is becoming critical to the fund manager’s perspective, as investors shift further to sustainable investment.
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...GET IN TOUCH